Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435
- 1 March 1982
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 25 (3) , 299-306
- https://doi.org/10.1016/0010-7824(82)90053-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435Contraception, 1981
- Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindroneContraception, 1979
- Evaluation of the double antibody-solid phase radioimmunoassay technique in plasma LH and FSH and urinary LH measurementsScandinavian Journal of Clinical and Laboratory Investigation, 1978
- Contraception with d-norgestrei silastic rods. Plasma levels of d-norgestrel and influence on the ovarian functionContraception, 1976
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976
- Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian functionContraception, 1976
- RADIOIMMUNOASSAY OF OESTRONE AND OESTRADIOL IN HUMAN AND BOVINE PERIPHERAL PLASMAActa Endocrinologica, 1972
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972
- EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.3 mg OF NOREHTINDRONE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF PREGNANEDIOL AND TOTAL OESTROGENSActa Endocrinologica, 1970
- EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.5 MG OF NORETHINDRONE ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF LUTEINIZING HORMONE, PREGNANEDIOL AND TOTAL OESTROGENSActa Endocrinologica, 1970